Rev1 Ventures

Rev1 Ventures

A venture capital firm in Ohio that seeks to identify start-ups and entrepreneurs that can benefit from connections, acceleration and funding.

Rev1 Ventures is a venture capital firm in Ohio that seeks to identify start-ups and entrepreneurs that can benefit from connections, acceleration and funding. Founded 2015 in Columbus, Ohio, United States, this venture capital firm invests in early stage ventures, seed and other ventures. Its portfolio companies include Deep Lens, EmployStream, Healthy Roster, Healthy Roster, MentorcliQ, NeuVanta, Prevedére, SHARE and Teraki. As of February 2020, Rev1 Ventures has made 208 investments. Their most recent investment was on February 10, 2020, when EmployStream raised $7M. Rev1 Ventures has had 14 exits, the most notable of which include Zebra TechnologiesAssurex Health, and Myonexus Therapeutics.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Deep Lens

Deep Lens is an Artificial Intelligence company matching patients with clinical trials.

Simple-Fill is changing the way vehicles are fueled with an innovative technology that compresses natural gas in a more affordable, reliable and efficient way.

Organization

Myonexus Therapeutics is a Columbus, Ohio-based company.

9 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Alicia Oddi

Senior Director, Entrepreneur & Inclusion Programs

Alison Lopriore

Manager, Service Provider & Mentor Engagement

Andrea Ewing

Manager, Corporate Connections

Andrew Daniels

Venture Analyst

Ann Marks

Administrative Assistant

Bethany George

Senior Director, Investment Funds

Chip Holcombe

Development Director

Clark McMahon

Employee

Cody Changet

Graphic Designer

David Bergeron

Senior Vice President, Venture Development

Edward Asare

Senior Business Intelligence Analyst

Erica Carlson

Market Intelligence Intern

Erik Berg

Analyst, Investment Funds

Greg Pugh

Employee

Heather Harmon

Director, Marketing & Community Outreach

John Hrivnak

Employee

John Schroepfer

Chief Financial Officer in Residenc

Joyce Booth

Administrative & Special Projects Associate

Julia Dewey

Senior Director, Corporate Partner Success

Kathleen Green

Executive Assistant to President & CEO

Mary Jane Grinstead

Marketing Consultant

Matt Chimes

Director, Entrepreneur Intake and Insights

Matt Cynkar

Senior Director, Market Intelligence & Analytics

Matt Veryser

Employee

Maurice McGee

Staff Accountant

Page 1 of 2

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Deep Lens

EmployStream

Healthy Roster

Healthy Roster

MentorcliQ

NeuVanta

Prevedére

SHARE

Teraki

News

Title
Author
Date
Publisher
Description
BioSpace
May 4, 2020
BioSpace
Today marks the launch of Clarametyx Biosciences Inc ., ("Clarametyx") a preclinical stage biotechnology company developing targeted, immune-enabling biologic therapies to counter persistent infections associated with biofilms. The company's lead candidate, CMTX-001, is a huma

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.